Opportunities Preloader

Please Wait.....

Report

United States Neurovascular Embolization Devices Market Assessment, By Product [Aneurysm Clips, Liquid Embolic Systems, Embolization Coils, Flow Diversion Stents, Intravascular Flow Disruptors], By Disease Pathology [Ischemic Strokes, Cerebral Aneurysm, Carotid Artery Stenosis, Arteriovenous Malformations and Fistulas, Other Diseases], By End Use [Hospitals, Ambulatory Surgical Centres, Specialty Clinics, Others], By Region, Opportunities, and Forecast, 2016-2030F

Market Report I 2024-04-19 I 81 Pages I Market Xcel - Markets and Data

Improved access to healthcare services and insurance coverage in the United States have resulted in a more robust infrastructure for treatment of neurovascular patients. The United States Neurovascular Embolization Devices market was valued at USD 328 million in 2022 and is projected to be growing at a CAGR of 8.51% from 2023 to 2030. The increasing prevalence of haemorrhages & anomalies in cerebral arteries, rising cases of brain aneurysms, and arteriovenous malformations (AVMs) due to sedentary lifestyles are the main causes of surge in demand for neurovascular embolization devices. In addition, factors driving the growth of the United States neurovascular embolization devices market includes increasing geriatric population, increasing number of patients with hypertension and the introduction of novel neurovascular embolization devices.
An intravascular implant called a neurovascular embolization device is designed to permanently cut off blood supply to brain aneurysms and arteriovenous malformations.
Increasing Number of Patients with Cerebral Aneurysm
In recent years, there has been an increasing number of cerebral aneurysm patients in the United States, which has led to a growing demand for neurovascular embolization devices in the market. The market for these devices has been growing as more patients are diagnosed with cerebral aneurysms and seek treatment. Ruptured brain aneurysm affects around 6.7 million people in the United States, or one in every fifty people. Women above the age 55, have a higher risk of cerebral aneurysm rupture as compared to men.
Technological Advancements
Technological advancements have made it possible to identify a size and shape of aneurysm. One major advancement is the development of new materials for embolization coils and flow diverters. These devices are used to block blood flow to abnormal blood vessels in the brain, and the new materials provide better visibility and control during the procedure. Additionally, there has been increased use of robotic systems for neurovascular procedures, which provide greater precision and control during the procedure.
Cerebral Embolization and Aneurysm Coiling Devices Account for Majority of Market Share
Cerebral embolization and aneurysm coiling devices led the neurovascular device market. More than 40% of the market was accounted for cerebral embolization and aneurysm coiling devices, which are widely used in the treatment of aneurysms and strokes. Rising healthcare costs, increased R&D spending, and rising frequency of neurological diseases such as brain aneurysms, stroke, and arteriovenous malformations (AVMs) are few factors driving the market expansion.


Impact of COVID-19 on the United States Neurovascular Embolization Devices Market
The pandemic had a significant impact on the United States Neurovascular Embolization Device Market. The market has witnessed a decline in growth due to the pandemic's impact on healthcare facilities' operations, as well as a reduction in demand for non-urgent medical procedures. Additionally, the disruption of supply chains caused by the pandemic has led to delays in the production and distribution of neurovascular embolization devices, further impacting the market's growth. The market bounced back to pre-pandemic levels after upliftment of lockdown.
Impact of Russia-Ukraine War on the United States Neurovascular Embolization Devices Market
The Russia-Ukraine war did not have a significant impact on the United States neurovascular embolization market. Although, the war disrupted the trade dynamics such as demand-supply, pricing variances, impact on import/export and trading activities between United States, Russia, and Ukraine. Economic sanctions imposed by United States impacted the export of devices to Russia.
Key Players Landscape and Outlook
The market for neurovascular devices is competitive and is dominated by major players. The key players in the market are Terumo Corporation, Johnson & Johnson, and Medtronic Plc, Microport Scientific Corporation, Integra Life Sciences Corporation, Penumbra Inc and many others.
In 2021, Medtronic recalled two of its transcatheter devices intended to seal brain aneurysms: the Pipeline Flex Embolization Device and the Pipeline Flex Embolization Device with Shield Technology. The wire and tubes fractured and broke down when the delivery systems were used to place, remove, or relocate the stent within a patient.
Market Xcel's reports answer the following questions:

- What is the current and future market size of the product/service in question globally or specific to different countries?
- How are the markets divided into different product/service segments and the market size and growth of each segment?
- What is the market potential of different product segments and their invest case?
- How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
- What is the business environment and regulatory landscape specific to the product/service?

1. Research Methodology
2. Project Scope & Definitions
3. Impact of Covid-19
4. Impact of Russia-Ukraine War Market
5. Executive Summary
6. United States Neurovascular Embolization Devices Market Outlook, 2016-2030F
6.1. Market Size & Forecast
6.1.1. By Value
6.1.2. By Volume
6.2. Market Share & Forecast
6.2.1. By Product
6.2.1.1. Aneurysm Clips
6.2.1.2. Liquid Embolic Systems
6.2.1.3. Embolization Coils
6.2.1.4. Flow Diversion Stents
6.2.1.5. Intrasaccular Flow Disruptors
6.2.2. By Disease Pathology
6.2.2.1. Ischemic Strokes
6.2.2.2. Cerebral Aneurysm
6.2.2.3. Carotid Artery Stenosis
6.2.2.4. Arteriovenous Malformations and fistulas
6.2.2.5. Other Diseases
6.2.3. By End User
6.2.3.1. Hospitals
6.2.3.2. Ambulatory Surgical Centers
6.2.3.3. Specialty Clinics
6.2.3.4. Others
6.2.4. Region
6.2.4.1. Northeast
6.2.4.2. Southwest
6.2.4.3. West
6.2.4.4. Southeast
6.2.4.5. Midwest
6.2.5. By Company Market Share (%), 2022
7. Market Mapping, 2022
7.1. By Product
7.2. By Disease Pathology
7.3. By End User
7.4. By Region
8. Macro Environment and Industry Structure
8.1. Supply Demand Analysis
8.2. Import Export Analysis
8.3. Value Chain Analysis
8.4. PESTEL Analysis of the Neurovascular Embolization Devices Market
8.4.1. Political Factors
8.4.2. Economic System
8.4.3. Social Implications
8.4.4. Technological Advancements
8.4.5. Environmental Impacts
8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
8.5. Porter's Five Forces Analysis
8.5.1. Supplier Power
8.5.2. Buyer Power
8.5.3. Substitution Threat
8.5.4. Threat from New Entrant
8.5.5. Competitive Rivalry
9. Market Dynamics
9.1. Growth Drivers
9.2. Growth Inhibitors
10. Regulatory Framework and Innovation
10.1. Clinical Trials
10.2. Patent Landscape
10.3. FDA Approvals
10.4. Product Innovations/Emerging Technologies
11. Case Studies
12. Pricing Analysis
13. Key Players Landscape
13.1. Competition Matrix of Top Five Market Leaders
13.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
13.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
13.4. SWOT Analysis (For Five Market Players)
14. Key Players Outlook
14.1. Microport Scientific Corporation
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Financials (As reported)
14.1.5. Key Market Focus & Geographical Presence
14.1.6. Recent Developments
14.2. Integra LifeSciences Corporation
14.3. Medtronic Plc
14.4. Terumo Corporation (MicroVention, Inc)
14.5. B. Braun Melsungen AG
14.6. Penumbra, Inc
14.7. Stryker Corporation
14.8. Kaneka Medical Products
14.9. Johnson & Johnson (Cerenovous)
14.10. Codman & Shrutleff, Inc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3300.00
  • $4500.00
  • $7000.00
  • ADD TO BASKET
  • BUY NOW